225 related articles for article (PubMed ID: 34601113)
1. Diagnostic value of cardiac natriuretic peptide on pulmonary hypertension in systemic sclerosis: A systematic review and meta-analysis.
Zhang Y; Qin D; Qin L; Yang X; Luo Q; Wang H
Joint Bone Spine; 2022 Mar; 89(2):105287. PubMed ID: 34601113
[TBL] [Abstract][Full Text] [Related]
2. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
[TBL] [Abstract][Full Text] [Related]
3. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
[TBL] [Abstract][Full Text] [Related]
5. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of brain natriuretic peptide and N-terminal brain natriuretic peptide for detecting paediatric pulmonary hypertension: a systematic review and meta-analysis.
Zhou R; Lei Y; Ge L; Mao Q; Yang L; Qiu X
Ann Med; 2024 Dec; 56(1):2352603. PubMed ID: 38753384
[TBL] [Abstract][Full Text] [Related]
7. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
[TBL] [Abstract][Full Text] [Related]
8. On the diagnostic test accuracy of N-terminal pro-brain natriuretic peptide (NT-proBNP) for pulmonary arterial hypertension in patients with systemic sclerosis. Comment on: "Diagnostic value of cardiac natriuretic peptide on pulmonary hypertension in systemic sclerosis: a systematic review and meta-analysis" by Zhang et al. Joint Bone Spine 2021:105287.
Simopoulou T; Grammatikopoulou MG; Gkiouras K; Bogdanos DP
Joint Bone Spine; 2022 May; 89(3):105317. PubMed ID: 34875375
[No Abstract] [Full Text] [Related]
9. N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers.
Allanore Y; Borderie D; Meune C; Cabanes L; Weber S; Ekindjian OG; Kahan A
Arthritis Rheum; 2003 Dec; 48(12):3503-8. PubMed ID: 14674001
[TBL] [Abstract][Full Text] [Related]
10. The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.
Thakkar V; Stevens W; Prior D; Youssef P; Liew D; Gabbay E; Roddy J; Walker JG; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
Arthritis Res Ther; 2013; 15(6):R193. PubMed ID: 24246100
[TBL] [Abstract][Full Text] [Related]
11. Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.
Mathai SC; Bueso M; Hummers LK; Boyce D; Lechtzin N; Le Pavec J; Campo A; Champion HC; Housten T; Forfia PR; Zaiman AL; Wigley FM; Girgis RE; Hassoun PM
Eur Respir J; 2010 Jan; 35(1):95-104. PubMed ID: 19643943
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of brain natriuretic peptides in patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
Hendriks PM; van de Groep LD; Veen KM; van Thor MCJ; Meertens S; Boersma E; Boomars KA; Post MC; van den Bosch AE
Am Heart J; 2022 Aug; 250():34-44. PubMed ID: 35533723
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis.
Ciurzyński M; Bienias P; Lichodziejewska B; Kurnicka K; Szewczyk A; Glińska-Wielochowska M; Kurzyna M; Błaszczyk M; Liszewska-Pfejfer D; Pruszczyk P
Clin Rheumatol; 2008 Aug; 27(8):991-7. PubMed ID: 18256871
[TBL] [Abstract][Full Text] [Related]
14. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
[TBL] [Abstract][Full Text] [Related]
16. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort.
Miller L; Chartrand S; Koenig M; Goulet JR; Rich É; Chin AS; Chartrand-Lefebvre C; Abrahamowicz M; Senécal JL; Grodzicky T
Scand J Rheumatol; 2014; 43(4):314-23. PubMed ID: 25089008
[TBL] [Abstract][Full Text] [Related]
17. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of nailfold videocapillaroscopy in systemic sclerosis secondary pulmonary arterial hypertension: a meta-analysis.
Xia Z; Wang G; Xiao H; Guo S; Liu Y; Meng F; Liu D; Li G; Zong L
Intern Med J; 2018 Nov; 48(11):1355-1359. PubMed ID: 29761614
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-BNP in sclerodermic patients on bosentan therapy for PAH.
Simeoni S; Lippi G; Puccetti A; Montagnana M; Tinazzi E; Prati D; Corrocher R; Lunardi C
Rheumatol Int; 2008 May; 28(7):657-60. PubMed ID: 18092166
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of N-terminal natriuretic peptides in systemic sclerosis: a single centre study.
Költő G; Vuolteenaho O; Szokodi I; Faludi R; Tornyos A; Ruskoaho H; Minier T; Czirják L; Komócsi A
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-75-81. PubMed ID: 25372791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
